Tuberculosis Diagnostics Market Is Estimated To Touch USD 3.1 Billion By 2024

16 Jan 2019 – Global Tuberculosis Diagnostics Market is anticipated to reach USD 3.1 billion by 2024 owing to the introduction of enhanced diagnostic techniques like serological methods, IGRA (Interferon-gamma Release Assay), and nucleic acid testing. Tuberculosis is an infectious disorder caused by mycobacterium tuberculosis bacteria that attacks the lungs. The disorder can also spread to the other parts of the body like spine and brain. Depending on the type of tuberculosis suspected in the body, several tests are available for the diagnosis.

Tuberculosis diagnostics industry is influenced by factors like quick results and improved accuracy, increasing government initiatives, growing elderly population and rising need for POC in healthcare sector. However, tuberculosis diagnostics market is restrained by significant cost of tuberculosis diagnosis and lack of awareness in patients. Additionally, the increasing burden of tuberculosis is the major factor expected to bring greater opportunities in tuberculosis diagnostics industry.

Browse Full Research Report @ https://www.millioninsights.com/industry-reports/tuberculosis-diagnostics-market

Tuberculosis diagnostics market is categorized on the basis of test type, end user, and geography. On the basis of test type, the market is divided into diagnostic laboratory methods, detection of latent infection, nucleic acid testing, cytokine detection assay, detection of drug resistance, radiographic method, and others. Diagnostic laboratory segment is projected to hold larger market share of tuberculosis diagnostics since it is easy to perform and cost effective.

Based on end user, tuberculosis diagnostics industry is divided into clinics, research institutes & academics, reference laboratories, hospitals, and others. Hospital segment is predicted to register significant growth in the coming years owing to rising preference for well-organized healthcare services by patients.

Geographically, tuberculosis diagnostics market is segmented as North America, Latin America, Europe, Asia Pacific and Middle East & Africa. North America is predicted to lead the market of tuberculosis diagnostics owing to innovations in technology, approval for novel medications and increasing incidences for TB in young people.

The prominent players in tuberculosis diagnostics industry include Abbott, BioMrieux SA, Hain Lifescience GmbH, Siemens, Cepheid, Thermo Fisher Scientific Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Hologic Corporation, and Qiagen.

Request Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/tuberculosis-diagnostics-market/request-sample

Market Segment:

Global Tuberculosis Diagnostics Test Type Outlook (Revenue, USD Million, 2013 – 2024)
• Radiographic Method
• Diagnostic Laboratory Methods
• Smear Microscopy
• Culture-based Test
• Nucleic Acid Testing
• Phage Assay
• Detection of Latent Infection
• Cytokine Detection Assay
• Detection of Drug Resistance
• Other Methods

Tuberculosis Diagnostics Regional Outlook (Revenue, USD Million, 2013 – 2024)
• North America
• U.S.
• Canada
• Europe
• UK
• Russian Federation
• Asia Pacific
• China
• India
• Latin America
• Brazil
• Mexico
• MEA
• South Africa

See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/healthcare

Contact Details:
Company Name: Million Insights
Contact Person: Ryan Manuel
Phone: 91-20-65300184
Toll Free: 1-866-831-4085
Email:sales@millioninsights.com
Address: Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India